163 related articles for article (PubMed ID: 16385575)
1. Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract.
He XY; Tang L; Wang SL; Cai QS; Wang JS; Hong JY
Int J Cancer; 2006 Jun; 118(11):2665-71. PubMed ID: 16385575
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2A13 enhances the sensitivity of human bronchial epithelial cells to aflatoxin B1-induced DNA damage.
Yang X; Zhang Z; Wang X; Wang Y; Zhang X; Lu H; Wang SL
Toxicol Appl Pharmacol; 2013 Jul; 270(2):114-21. PubMed ID: 23602888
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1.
Zhang Z; Lu H; Huan F; Meghan C; Yang X; Wang Y; Wang X; Wang X; Wang SL
Int J Cancer; 2014 Apr; 134(7):1539-48. PubMed ID: 24114584
[TBL] [Abstract][Full Text] [Related]
4. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
5. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
6. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.
Zhu LR; Thomas PE; Lu G; Reuhl KR; Yang GY; Wang LD; Wang SL; Yang CS; He XY; Hong JY
Drug Metab Dispos; 2006 Oct; 34(10):1672-6. PubMed ID: 16815959
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of aflatoxins: key enzymes and interindividual as well as interspecies differences.
Dohnal V; Wu Q; Kuča K
Arch Toxicol; 2014 Sep; 88(9):1635-44. PubMed ID: 25027283
[TBL] [Abstract][Full Text] [Related]
8. Interaction of aflatoxin B1 with cytochrome P450 2A5 and its mutants: correlation with metabolic activation and toxicity.
Pelkonen P; Lang MA; Negishi M; Wild CP; Juvonen RO
Chem Res Toxicol; 1997 Jan; 10(1):85-90. PubMed ID: 9074807
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems.
Neal GE; Eaton DL; Judah DJ; Verma A
Toxicol Appl Pharmacol; 1998 Jul; 151(1):152-8. PubMed ID: 9705898
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells.
Yang XJ; Lu HY; Li ZY; Bian Q; Qiu LL; Li Z; Liu Q; Li J; Wang X; Wang SL
Toxicology; 2012 Oct; 300(3):138-48. PubMed ID: 22743290
[TBL] [Abstract][Full Text] [Related]
11. Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1.
Li AP
Chem Biol Interact; 2009 Apr; 179(1):4-8. PubMed ID: 18950609
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of aflatoxin B1 by rabbit and rat nasal mucosa microsomes and purified cytochrome P450, including isoforms 2A10 and 2A11.
Putt DA; Ding X; Coon MJ; Hollenberg PF
Carcinogenesis; 1995 Jun; 16(6):1411-7. PubMed ID: 7788862
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of aflatoxin B1 by normal human bronchial epithelial cells.
Van Vleet TR; Klein PJ; Coulombe RA
J Toxicol Environ Health A; 2001 Aug; 63(7):525-40. PubMed ID: 11497333
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin B1 activation in human lung.
Kelly JD; Eaton DL; Guengerich FP; Coulombe RA
Toxicol Appl Pharmacol; 1997 May; 144(1):88-95. PubMed ID: 9169073
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells.
Zhang Z; Yang X; Wang Y; Wang X; Lu H; Zhang X; Xiao X; Li S; Wang X; Wang SL
Arch Toxicol; 2013 Sep; 87(9):1697-707. PubMed ID: 23907605
[TBL] [Abstract][Full Text] [Related]
16. Heterologous expression of CYP2K1 and identification of the expressed protein (BV-CYP2K1) as lauric acid (omega-1)-hydroxylase and aflatoxin B1 exo-epoxidase.
Yang YH; Miranda CL; Henderson MC; Wang-Buhler JL; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1279-83. PubMed ID: 11038153
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and expression of a novel cytochrome p450 from turkey liver with aflatoxin b1 oxidizing activity.
Yip SS; Coulombe RA
Chem Res Toxicol; 2006 Jan; 19(1):30-7. PubMed ID: 16411653
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B
Deng J; Zhao L; Zhang NY; Karrow NA; Krumm CS; Qi DS; Sun LH
Mutat Res Rev Mutat Res; 2018; 778():79-89. PubMed ID: 30454686
[TBL] [Abstract][Full Text] [Related]
19. miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.
Wang Y; Zhang Z; Wang H; Zhang Y; Ji M; Xu H; Wang C; Sun Z; Gao W; Wang SL
Arch Toxicol; 2016 May; 90(5):1239-49. PubMed ID: 26084420
[TBL] [Abstract][Full Text] [Related]
20. Modulation of aflatoxin B1 biotransformation by beta-naphthoflavone in isolated rabbit lung cells.
Im SH; Bolt MW; Stewart RK; Massey TE
Arch Toxicol; 1996; 71(1-2):72-9. PubMed ID: 9010588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
